Cargando…
Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer
BACKGROUND: Our objective was to determine if previously reported overall survival (OS) and progression-free survival (PFS) rates are maintained long term following multimodal therapy for advanced and recurrent endometrial cancer and to assess the lymphedema rates associated with this therapy. METHO...
Autores principales: | Glasgow, Michelle, Vogel, Rachel Isaksson, Burgart, Jennifer, Argenta, Peter, Dusenbery, Kathryn, Geller, Melissa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940984/ https://www.ncbi.nlm.nih.gov/pubmed/27408749 http://dx.doi.org/10.1186/s40661-016-0027-4 |
Ejemplares similares
-
Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
por: Wang, Shao-Jing, et al.
Publicado: (2022) -
Robot-assisted versus laparoscopic minimally invasive surgery for the treatment of stage I endometrial cancer
por: Argenta, Peter A., et al.
Publicado: (2022) -
USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment
por: Vogel, Rachel Isaksson, et al.
Publicado: (2016) -
Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010) -
An Allyl Uranium(IV) Sandwich Complex: Are ϕ Bonding Interactions Possible?
por: Popov, Ivan A., et al.
Publicado: (2022)